Betadine against SARS-CoV-2

Effectiveness of BETADINE Antiseptic Products against SARS-CoV-2. Mundipharma had announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE antiseptic products against the novel coronavirus (SARS-CoV-2) that causes COVID-19 disease. Testing has demonstrated BETADINE’s strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The products subjected to testing were: BETADINE antiseptic products, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I). These results confirm the view that BETADINE antiseptic products, used appropriately and in conjunction with other preventative treatment options including PPE, can play a role in limiting the spread of infections, including COVID-19. It also provides the medical community as well as consumers with a science-based assurance that they are using a product that is a proven defense against COVID-19. Previously, BETADINE antiseptic products containing povidone iodine (PVP-I) have been proven effective in vitro against a wide range of viruses, including coronaviruses that have caused major outbreaks such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The BETADINE antiseptic range contains Povidone-iodine (PVP-I), which is highly effective against a wide range of microorganisms, including bacteria, viruses and fungi and is typically used in hospitals.



A new update for all of us . May be it will help -surgeons , Gynaecologists and orthopedic surgeons as they are using betadine scrub - prior to all surgeries

Valuable opinion

Very well illustrated

Thank you doctor

As per icmr add in list if advantage

Nice information

Thank you doctor

Intresting update


Diseases Related to Discussion

Cases that would interest you